Jupiter Neurosciences (JUNS) Interest Coverage Ratio (2023 - 2025)
Jupiter Neurosciences (JUNS) posted quarterly Interest Coverage Ratio of 44.97 for Q4 2025, down 272.14% year-over-year from 26.12 in Q4 2024, and down 16605.99% quarter-over-quarter from 0.27 in Q3 2025.
Jupiter Neurosciences (JUNS) Interest Coverage Ratio (2023 - 2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Interest Coverage Ratio for 3 consecutive years, with 44.97 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Coverage Ratio fell 272.14% year-over-year to 44.97; the TTM figure through Dec 2025 stood at 69.23 (down 131.02% YoY), while the FY2025 annual figure was 5.03, down 16636.96% from the prior year.
- Interest Coverage Ratio retreated to 44.97 in Q4 2025 per JUNS's latest filing, from 0.27 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 26.12 in Q4 2024 and bottomed at 44.97 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 7.55 across 3 years, with a median of 6.23 in 2024.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio surged 278.24% — and 2025, when it slumped 272.14%.
- Jupiter Neurosciences' Interest Coverage Ratio stood at 14.66 in 2023, then jumped by 278.24% to 26.12 in 2024, then plunged by 272.14% to 44.97 in 2025.
- Business Quant data shows JUNS's Interest Coverage Ratio at 44.97 in Q4 2025, 0.27 in Q3 2025, and 1.28 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Jupiter Neurosciences | 3.37 Mn | 1.85 Mn | 21,064.00 | -30.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -44.97 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -1.28 |
| Mar 31, 2025 | -3.79 |
| Dec 31, 2024 | 26.12 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | -9.90 |
| Mar 31, 2024 | -8.68 |
| Dec 31, 2023 | -14.66 |
| Sep 30, 2023 | -17.89 |